HHS Price Forum: Surprisingly Good Context For Pharma Ideas For Regulatory Changes

The Obama Administration’s public forum to discuss responses to high drug prices sounded like a major threat to innovator companies. But it provided a setting to press for changes in marketing regulation sought by industry for years.